1. Chronic restraint stress promotes gastric epithelial malignant transformation by activating the Akt/p53 signaling pathway via ADRB2
   Chuanju Zong et al, 2022, Oncology Letters CrossRef
2. Rosmarinic acid plus deferasirox inhibits ferroptosis to alleviate crush syndrome-related AKI via Nrf2/Keap1 pathway
   Ou Qiao et al, 2024, Phytomedicine CrossRef
3. Crush syndrome: a review for prehospital providers and emergency clinicians
   Daisuke Usuda et al, 2023, Journal of Translational Medicine CrossRef
4. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment
   Ou Qiao et al, 2023, Journal of Advanced Research CrossRef
5. Crush syndrome-related acute kidney injury in earthquake victims
   Gonzalo Ramírez-Guerrero et al, 2023, Journal of Translational Critical Care Medicine CrossRef
6. BREAKING NEW GROUND: STANDARDIZING RAT MODELS FOR CRUSH SYNDROME INVESTIGATIONS
   Duo Li et al, 2024, Shock CrossRef
7. Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes
   Guannan He et al, 2023, Pharmaceutics CrossRef
8. Cardiovascular events in crush syndrome: on-site therapeutic strategies and pharmacological investigations
   Meng-Wan Zhang et al, 2024, Frontiers in Pharmacology CrossRef
9. Targeting neutrophils extracellular traps, a promising anti-thrombotic therapy for natural products from traditional Chinese herbal medicine
   Wei Lei et al, 2024, Biomedicine & Pharmacotherapy CrossRef